Ipca Laboratories

Quarterly
Consolidated
ParticularsJun '25Sep '25Dec '25Mar '26Jun '26
Revenue2,3422,5842,4132,4822,813
Expenses2,0112,1351,9842,0322,241
EBITDA449.08572.78553.54577.61694.77
Operating Profit349.02411.19463.60424.65583.96
Profit Before Tax330.51391.58445.98404.45572.08
Net Profit234.42283.50364.05309.40422.81
Financial Ratios
Operating Profit Margin19.45%20.13%23.87%22.26%24.92%
Net Profit Margin10.10%12.70%13.08%13.96%14.41%
Earning Per Share (Diluted)9.1911.1412.8611.7915.84
Dividends Per Share0.000.000.000.000.00